NTHI Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
5.8M
-58.5%
14.1M
+99.4%
7.1M
-48.5%
13.7M
+97.5%
6.9M
R&D
1.3M
-50.7%
2.6M
+106.0%
1.3M
+3.1%
1.2M
+74.5%
715.0K
SG&A
1.8M
-77.0%
7.8M
+77.7%
4.4M
-81.8%
24.2M
+288.9%
6.2M
Operating Income
-5834350
+58.5%
-14069887
-99.4%
-7055662
+48.5%
-13696922
-97.5%
-6934647
EBITDA
-5827406
+58.6%
-14062942
-99.6%
-7044088
+48.6%
-13696922
-97.5%
-6934647
Net Income
-4440209
+68.8%
-14240044
-61.5%
-8819932
+43.2%
-15524104
-80.2%
-8615920
EPS (Basic)
$-0.28
+51.7%
$-0.58
-52.6%
$-0.38
+47.9%
$-0.73
-62.2%
$-0.45
EPS (Diluted)
$-0.28
+51.7%
$-0.58
-52.6%
$-0.38
+47.9%
$-0.73
-62.2%
$-0.45
Shares (Diluted)
25.8M
+4.5%
24.7M
+5.9%
23.3M
+9.8%
21.2M
+10.5%
19.2M
NeOnc Technologies (NTHI) — Financials